New bionic hand aims to restore grip and confidence
NCT ID NCT07135947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new powered prosthetic hand system called Point Powered in 10 adults who have lost part of their hand. The device uses muscle signals to control moving fingers. Researchers will compare it to each person's current prosthetic to see if it improves hand function, daily activities, and quality of life over three months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Point Powered partial hand prosthetic system
- What this could lead to
- If it works, this could offer people with partial hand loss a more functional, waterproof prosthetic that helps them do everyday tasks more easily.
- What could go wrong
- This is a very small early study with only 10 people. The device may not work better than current options, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Partial unilateral hand loss with at least index and/or middle fingers amputated at the MCP level * Intact thumb with full range of motion * Fluent in English * Age of 18 years or older Exclusion Criteria: * Patients with a residual limb that is unhealed from the amputation surgery * Unhealed wounds * Significant cognitive deficits as determined upon clinical evaluation * Significant neurological deficits as determined upon clinical evaluation * Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation * Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation * Serious uncontrolled medical problems as judged by the project therapist
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Amputation; traumatic, hand are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hanger Clinic
Lafayette, Colorado, 80026, United States
-
Point Designs
Broomfield, Colorado, 80020, United States
-
University of Colorado Denver | Anschutz Medical Campus
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.